Literature DB >> 2122580

Skin deposits in hereditary cystatin C amyloidosis.

E Benedikz1, H Blöndal, G Gudmundsson.   

Abstract

Clinically normal skin from 47 individuals aged 9-70 years was investigated. Cystatin C amyloid deposits were found in various locations of the skin by light and/or electron microscopy, in all 12 patients with a clinical history of hereditary cystatin C amyloidosis (HCCA). Six asymptomatic individuals, who had the Alu 1 restriction fragment length polymorphism (RFLP) marker reported to cosegregate with the disease, also had cystatin C amyloid deposits in the skin. Three asymptomatic individuals (age 17-46) belonging to the HCCA families were without amyloid in the skin but had Alu 1 RFLP marker. Skin from 12 individuals who served as controls and skin from 14 close relatives of the patients was negative for amyloid. Punch biopsy of the skin is a simple procedure which is of value for the diagnosis of HCCA, even before the appearance of clinical symptoms. This method might also be of use in following progression of the disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2122580     DOI: 10.1007/bf01605784

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  21 in total

Review 1.  Human cysteine proteinase inhibitors. Isolation, physiological importance, inhibitory mechanism, gene structure and relation to hereditary cerebral hemorrhage.

Authors:  M Abrahamson
Journal:  Scand J Clin Lab Invest Suppl       Date:  1988

2.  Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis.

Authors:  F Coria; E Castaño; F Prelli; M Larrondo-Lillo; S van Duinen; M L Shelanski; B Frangione
Journal:  Lab Invest       Date:  1988-04       Impact factor: 5.662

3.  Hereditary cerebral haemorrhage with amyloidosis.

Authors:  G Gudmundsson; J Hallgrímsson; T A Jónasson; O Bjarnason
Journal:  Brain       Date:  1972       Impact factor: 13.501

4.  The cutaneous amyloidoses. II. Systemic forms.

Authors:  M H Brownstein; E B Helwig
Journal:  Arch Dermatol       Date:  1970-07

Review 5.  Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts).

Authors:  G G Glenner
Journal:  N Engl J Med       Date:  1980-06-05       Impact factor: 91.245

6.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

7.  Abnormal metabolism of gamma-trace alkaline microprotein. The basic defect in hereditary cerebral hemorrhage with amyloidosis.

Authors:  A Grubb; O Jensson; G Gudmundsson; A Arnason; H Löfberg; J Malm
Journal:  N Engl J Med       Date:  1984-12-13       Impact factor: 91.245

8.  Quantitation of gamma-trace in human biological fluids: indications for production in the central nervous system.

Authors:  H Löfberg; A O Grubb
Journal:  Scand J Clin Lab Invest       Date:  1979-11       Impact factor: 1.713

9.  Hereditary cerebral amyloid angiopathy: the amyloid fibrils contain a protein which is a variant of cystatin C, an inhibitor of lysosomal cysteine proteases.

Authors:  J Ghiso; B Pons-Estel; B Frangione
Journal:  Biochem Biophys Res Commun       Date:  1986-04-29       Impact factor: 3.575

10.  Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases.

Authors:  E Levy; C Lopez-Otin; J Ghiso; D Geltner; B Frangione
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

View more
  9 in total

1.  Pathological changes in basement membranes and dermal connective tissue of skin from patients with hereditary cystatin C amyloid angiopathy.

Authors:  Asbjorg Osk Snorradottir; Helgi J Isaksson; Saevar Ingthorsson; Elias Olafsson; Astridur Palsdottir; Birkir Thor Bragason
Journal:  Lab Invest       Date:  2017-01-09       Impact factor: 5.662

2.  Hereditary cystatin C amyloid angiopathy: monitoring the presence of the Leu-68-->Gln cystatin C variant in cerebrospinal fluids and monocyte cultures by MS.

Authors:  B Asgeirsson; S Haebel; L Thorsteinsson; E Helgason; K O Gudmundsson; G Gudmundsson; P Roepstorff
Journal:  Biochem J       Date:  1998-02-01       Impact factor: 3.857

3.  Increased body temperature accelerates aggregation of the Leu-68-->Gln mutant cystatin C, the amyloid-forming protein in hereditary cystatin C amyloid angiopathy.

Authors:  M Abrahamson; A Grubb
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

4.  Hereditary cystatin C amyloid angiopathy: identification of the disease-causing mutation and specific diagnosis by polymerase chain reaction based analysis.

Authors:  M Abrahamson; S Jonsdottir; I Olafsson; O Jensson; A Grubb
Journal:  Hum Genet       Date:  1992-06       Impact factor: 4.132

Review 5.  Molecular biology of Alzheimer's amyloid--Dutch variant.

Authors:  T Wisniewski; B Frangione
Journal:  Mol Neurobiol       Date:  1992       Impact factor: 5.590

Review 6.  Unifying features of systemic and cerebral amyloidosis.

Authors:  J Ghiso; T Wisniewski; B Frangione
Journal:  Mol Neurobiol       Date:  1994-02       Impact factor: 5.590

7.  Hereditary amyloid cardiomyopathy caused by a variant apolipoprotein A1.

Authors:  L Hamidi Asl; J J Liepnieks; K Hamidi Asl; T Uemichi; G Moulin; E Desjoyaux; R Loire; M Delpech; G Grateau; M D Benson
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

Review 8.  Cystatin C--properties and use as diagnostic marker.

Authors:  A O Grubb
Journal:  Adv Clin Chem       Date:  2000       Impact factor: 5.394

9.  NAC blocks Cystatin C amyloid complex aggregation in a cell system and in skin of HCCAA patients.

Authors:  Michael E March; Alvaro Gutierrez-Uzquiza; Asbjorg Osk Snorradottir; Leticia S Matsuoka; Noelia Fonseca Balvis; Thorgeir Gestsson; Kenny Nguyen; Patrick M A Sleiman; Charlly Kao; Helgi J Isaksson; Birkir Thor Bragason; Elias Olafsson; Astridur Palsdottir; Hakon Hakonarson
Journal:  Nat Commun       Date:  2021-03-23       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.